The company's Flex Robotic System is designed for operating on the throat and voice box
By RBR Staff
December 20, 2012
Raynham-based Medrobotics Corp., an emerging medical robotics company developing the innovative Flex™ Robotic System, announced today the conversion of notes totaling $33.6 Million purchased through recent financings into Series D Preferred Stock. Existing Medrobotics shareholders and undisclosed new investors participated in the Series D raise. Proceeds will be used for regulatory preparations and submissions and for anticipated commercial launches next year in Europe and the United States.
“Patients, surgeons, and hospitals will all benefit from the Flex Robotic System’s enabling minimally invasive surgical technology,” said Samuel Straface, Ph.D., president and CEO of Medrobotics. “The Flex Robotic System will…
To continue reading, join today.
Want to learn more about our membership options? Give me a call.
Pat Kelly, Robotics Membership Manager
508-663-1500 x 482 | email@example.com